2023 Q4 Form 10-Q Financial Statement

#000165495423014575 Filed on November 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $62.00K $401.0K
YoY Change -84.54% -59.98%
Cash & Equivalents €62.00K €401.0K
Short-Term Investments
Other Short-Term Assets $24.00K $138.0K
YoY Change -82.61% 8.66%
Inventory
Prepaid Expenses €24.00K €138.0K
Receivables €13.00K €58.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets €99.00K €597.0K
YoY Change -83.42% -48.58%
LONG-TERM ASSETS
Property, Plant & Equipment €1.000K €30.00K
YoY Change -96.67% -31.82%
Goodwill €0.00 €6.671M
YoY Change -100.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $10.00K
YoY Change -100.0% 0.0%
Total Long-Term Assets €1.000K €6.870M
YoY Change -99.99% 1.39%
TOTAL ASSETS
Total Short-Term Assets €99.00K €597.0K
Total Long-Term Assets €1.000K €6.870M
Total Assets €100.0K €7.467M
YoY Change -98.66% -5.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable €559.0K €48.00K
YoY Change 1064.58% -31.43%
Accrued Expenses $0.00 $106.0K
YoY Change -100.0% 96.3%
Deferred Revenue
YoY Change
Short-Term Debt $74.97M $71.07M
YoY Change 5.49% 6.85%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities €75.53M €71.22M
YoY Change 6.04% 6.86%
LONG-TERM LIABILITIES
Long-Term Debt €145.0K €176.0K
YoY Change -17.61% 12.82%
Other Long-Term Liabilities $0.00 $57.00K
YoY Change -100.0%
Total Long-Term Liabilities €145.0K €233.0K
YoY Change -37.77% 49.36%
TOTAL LIABILITIES
Total Short-Term Liabilities €75.53M €71.22M
Total Long-Term Liabilities €145.0K €233.0K
Total Liabilities €75.67M €71.45M
YoY Change 5.9% 6.96%
SHAREHOLDERS EQUITY
Retained Earnings -€113.2M -€101.6M
YoY Change 11.38% -205.31%
Common Stock €2.530M €2.530M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -€75.57M -€63.99M
YoY Change
Total Liabilities & Shareholders Equity €100.0K €7.467M
YoY Change -98.66% -5.92%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7321000 eur
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
313000 eur
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13000 eur
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
62000 eur
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
106000 eur
CY2023Q3 us-gaap Assets Current
AssetsCurrent
99000 eur
CY2022Q4 us-gaap Assets Current
AssetsCurrent
481000 eur
CY2023Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
0 eur
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
10000 eur
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1000 eur
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26000 eur
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 eur
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
133000 eur
CY2023Q3 us-gaap Goodwill
Goodwill
0 eur
CY2022Q4 us-gaap Goodwill
Goodwill
6671000 eur
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
213000 eur
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 eur
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
7000 eur
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 eur
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
106000 eur
CY2023Q3 mymx Non Convertible Notes Payable And Related Accrued Interest To Related Parties
NonConvertibleNotesPayableAndRelatedAccruedInterestToRelatedParties
11755000 eur
CY2022Q4 mymx Non Convertible Notes Payable And Related Accrued Interest To Related Parties
NonConvertibleNotesPayableAndRelatedAccruedInterestToRelatedParties
10461000 eur
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
75525000 eur
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
72030000 eur
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
145000 eur
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
156000 eur
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
187000 eur
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
2530000 eur
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-102555000 eur
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
672000 eur
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
686000 eur
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-75570000 eur
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-64896000 eur
CY2018Q2 us-gaap Investment Interest Rate
InvestmentInterestRate
0.025 pure
CY2019Q2 us-gaap Investment Interest Rate
InvestmentInterestRate
0.025 pure
CY2019Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.025 pure
dei Entity Central Index Key
EntityCentralIndexKey
0000927761
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1200000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
303757622 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
303757622 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
303757622 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
793630391 shares
mymx Basic Weighted And Diluted Number Of Share
BasicWeightedAndDilutedNumberOfShare
303757622 shares
CY2023Q3 mymx Basic Weighted And Diluted Number Of Share
BasicWeightedAndDilutedNumberOfShare
303757622 shares
CY2023Q3 us-gaap Interest Paid
InterestPaid
500.0 eur
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-25132
dei Entity Registrant Name
EntityRegistrantName
MYMETICS CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
25-1741849
dei Entity Address Address Line1
EntityAddressAddressLine1
c/o Mymetics SA
dei Entity Address Address Line2
EntityAddressAddressLine2
Route de la Corniche 4
dei Entity Address City Or Town
EntityAddressCityOrTown
Epalinges
dei Entity Address Country
EntityAddressCountry
CH
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
1066
dei City Area Code
CityAreaCode
011
dei Local Phone Number
LocalPhoneNumber
41 21 566 57 72
dei Security12b Title
Security12bTitle
Common Stock, Par Value $0.01 per share
dei Trading Symbol
TradingSymbol
MYMX
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
303757622 shares
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62000 eur
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
24000 eur
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
498000 eur
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
475000 eur
CY2023Q3 us-gaap Assets
Assets
100000 eur
CY2022Q4 us-gaap Assets
Assets
7321000 eur
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
559000 eur
CY2023Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
63211000 eur
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
61243000 eur
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 eur
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
31000 eur
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
145000 eur
CY2023Q3 us-gaap Liabilities
Liabilities
75670000 eur
CY2022Q4 us-gaap Liabilities
Liabilities
72217000 eur
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 eur
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 eur
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1200000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
303757622 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2530000 eur
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 eur
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 eur
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
34443000 eur
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
34443000 eur
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-113215000 eur
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
100000 eur
CY2023Q3 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
0 eur
CY2022Q3 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
0 eur
us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
3000 eur
us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
0 eur
CY2023Q3 mymx Other Income Grants
OtherIncomeGrants
34000 eur
CY2022Q3 mymx Other Income Grants
OtherIncomeGrants
130000 eur
mymx Other Income Grants
OtherIncomeGrants
411000 eur
mymx Other Income Grants
OtherIncomeGrants
909000 eur
CY2023Q3 us-gaap Revenues
Revenues
34000 eur
CY2022Q3 us-gaap Revenues
Revenues
130000 eur
us-gaap Revenues
Revenues
414000 eur
us-gaap Revenues
Revenues
909000 eur
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
60000 eur
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
209000 eur
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
854000 eur
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1191000 eur
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
355000 eur
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
320000 eur
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1515000 eur
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
979000 eur
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
415000 eur
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
529000 eur
us-gaap Costs And Expenses
CostsAndExpenses
2369000 eur
us-gaap Costs And Expenses
CostsAndExpenses
2170000 eur
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-381000 eur
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-399000 eur
us-gaap Operating Income Loss
OperatingIncomeLoss
-1955000 eur
us-gaap Operating Income Loss
OperatingIncomeLoss
-1261000 eur
CY2023Q3 us-gaap Interest Expense
InterestExpense
710000 eur
CY2022Q3 us-gaap Interest Expense
InterestExpense
703000 eur
us-gaap Interest Expense
InterestExpense
2118000 eur
us-gaap Interest Expense
InterestExpense
2096000 eur
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 eur
CY2022Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 eur
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
6671000 eur
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 eur
CY2023Q3 us-gaap Other General Expense
OtherGeneralExpense
23000 eur
CY2022Q3 us-gaap Other General Expense
OtherGeneralExpense
243000 eur
us-gaap Other General Expense
OtherGeneralExpense
84000 eur
us-gaap Other General Expense
OtherGeneralExpense
541000 eur
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1114000 eur
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1345000 eur
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10660000 eur
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3898000 eur
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 eur
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 eur
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 eur
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 eur
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1114000 eur
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1345000 eur
us-gaap Net Income Loss
NetIncomeLoss
-10660000 eur
us-gaap Net Income Loss
NetIncomeLoss
-3898000 eur
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-5000 eur
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-7000 eur
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-14000 eur
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-2000 eur
CY2023Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-1119000 eur
CY2022Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-1352000 eur
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-10674000 eur
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-3900000 eur
CY2023Q3 mymx Earnings Per Share Basic And Dilutive
EarningsPerShareBasicAndDilutive
-0.00
CY2022Q3 mymx Earnings Per Share Basic And Dilutive
EarningsPerShareBasicAndDilutive
-0.00
mymx Earnings Per Share Basic And Dilutive
EarningsPerShareBasicAndDilutive
-0.04
mymx Earnings Per Share Basic And Dilutive
EarningsPerShareBasicAndDilutive
-0.01
CY2023Q3 mymx Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
303757622000 shares
CY2022Q3 mymx Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
303757622000 shares
mymx Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
303757622000 shares
mymx Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
303757622000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-60086000 eur
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1211000 eur
CY2022Q1 mymx Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustment
7000 eur
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-61290000 eur
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1342000 eur
CY2022Q2 mymx Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustment
-2000 eur
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-62634000 eur
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1345000 eur
CY2022Q3 mymx Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustment
-7000 eur
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-63986000 eur
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-64896000 eur
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1861000 eur
CY2023Q1 mymx Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustment
0 eur
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-66757000 eur
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-7685000 eur
CY2023Q2 mymx Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustment
-9000 eur
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-74451000 eur
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1114000 eur
CY2023Q3 mymx Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustment
-5000 eur
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-75570000 eur
us-gaap Profit Loss
ProfitLoss
10660000 eur
us-gaap Profit Loss
ProfitLoss
3898000 eur
us-gaap Depreciation
Depreciation
9000 eur
us-gaap Depreciation
Depreciation
11000 eur
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
6671000 eur
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 eur
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
75000 eur
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 eur
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-49000 eur
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
43000 eur
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1968000 eur
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2436000 eur
mymx Increase Decrease In Other Interest Payable Net
IncreaseDecreaseInOtherInterestPayableNet
194000 eur
mymx Increase Decrease In Other Interest Payable Net
IncreaseDecreaseInOtherInterestPayableNet
161000 eur
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
346000 eur
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1000 eur
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-81000 eur
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
34000 eur
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1417000 eur
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1366000 eur
us-gaap Proceeds From Sale Of Flight Equipment
ProceedsFromSaleOfFlightEquipment
94000 eur
us-gaap Proceeds From Sale Of Flight Equipment
ProceedsFromSaleOfFlightEquipment
0 eur
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 eur
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2000 eur
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
94000 eur
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2000 eur
us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
14000 eur
us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
0 eur
mymx Proceeds From Issuance Of Non Convertible Stock
ProceedsFromIssuanceOfNonConvertibleStock
1100000 eur
mymx Proceeds From Issuance Of Non Convertible Stock
ProceedsFromIssuanceOfNonConvertibleStock
1200000 eur
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1086000 eur
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1200000 eur
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-14000 eur
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2000 eur
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-251000 eur
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-170000 eur
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
313000 eur
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
571000 eur
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62000 eur
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
401000 eur
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 eur
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 eur
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 eur
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 eur
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-113215000 eur
CY2023Q3 mymx Exceed Current Liabilities
ExceedCurrentLiabilities
75426000 eur
mymx Description Of Overall Budget
DescriptionOfOverallBudget
The overall budget related to the project is US$8,850 with US$8,761 approved for the period of (May 2019 to April 2024). This includes the funds approved for the period of May 2023 to April 2024 of US$1’630
mymx Description Of Grant Allocated
DescriptionOfGrantAllocated
The amounts mentioned in the following statements are purely related to the Company and not to the other partners in the project: The overall portion of the grant allocated to the Company is US$4,052 approved for the period of May 2019 to April 2024. This includes the funds approved for the period of May 2023 to April 2024 of US$97. In March 2023, an amendment to the contract was signed to reduce the allocated funds from ULL to the Company from US$1,328 to US$ 815, as more funds were allocated to the animal studies at ULL
CY2023Q3 mymx Sub Award Grant Revenue Us Dollar
SubAwardGrantRevenueUSDollar
36000 usd
CY2023Q3 mymx Sub Award Grant Revenue Euro
SubAwardGrantRevenueEuro
30000 eur
mymx Sub Award Grant Revenue Us Dollar
SubAwardGrantRevenueUSDollar
440000 usd
mymx Sub Award Grant Revenue Euro
SubAwardGrantRevenueEuro
406000 eur
mymx Basic Weighted And Diluted Number Of Share
BasicWeightedAndDilutedNumberOfShare
303757622 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
830150223 shares
CY2023Q3 mymx Weighted Average Number Of Shares Contingently Convertible Loans
WeightedAverageNumberOfSharesContingentlyConvertibleLoans
804400223 shares
CY2022Q3 mymx Basic Weighted And Diluted Number Of Share
BasicWeightedAndDilutedNumberOfShare
303757622 shares
us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
793630391 shares
CY2022Q3 mymx Weighted Average Number Of Shares Contingently Convertible Loans
WeightedAverageNumberOfSharesContingentlyConvertibleLoans
767880391 shares
us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
25750000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company derived 99% and 100% of grant revenue for the nine-month periods ended September 30, 2023 and 2022, respectively, from one grantor, respectively. For the period ended December 31, 2022, the Company derived 100% of grant revenue from one partner.</p>
CY2023Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
74483000 eur
CY2023Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
74966000 eur
CY2023Q3 us-gaap Debt Default Shortterm Debt Amount
DebtDefaultShorttermDebtAmount
38676000 eur
us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
36290000 eur
CY2023Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
74966000 eur
mymx Description Of Conversion Price
DescriptionOfConversionPrice
(i) reducing by 10% the price per share of the Company’s common stock paid by the investors in connection with an investment in the Company of not less than US$20,000, or (ii) at the fixed conversion price using a fixed exchange rate which are noted in the table above
CY2017Q1 us-gaap Investment Interest Rate
InvestmentInterestRate
0.025 pure
CY2017Q1 us-gaap Debt Instrument Description
DebtInstrumentDescription
The first 50% of the promissory Notes of €920 and €230, respectively, were provided immediately. The second 50% of the promissory notes of €920 and €230, respectively, were provided on October 18, 2017, with a 2.5% interest per annum and a maturity date of October 18, 2018
CY2018Q2 us-gaap Debt Instrument Description
DebtInstrumentDescription
The first tranche of the promissory Notes of €640 and €160, respectively, were provided immediately. The second tranche of the promissory notes of €640 and €160, respectively, were provided on November 10, 2018, with a 2.5% interest per annum
CY2019Q2 mymx Promissory Notes
PromissoryNotes
600000 eur
CY2019Q2 us-gaap Debt Instrument Description
DebtInstrumentDescription
The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) December 31, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes
CY2019Q4 mymx Promissory Notes
PromissoryNotes
600000 eur
CY2019Q4 us-gaap Debt Instrument Description
DebtInstrumentDescription
The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) June 30, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes
CY2020Q2 mymx Promissory Notes
PromissoryNotes
1100000 eur
CY2020Q2 us-gaap Investment Interest Rate
InvestmentInterestRate
0.025 pure
CY2020Q2 us-gaap Debt Instrument Description
DebtInstrumentDescription
The promissory Notes of €880 and €220, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) September 30, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes
CY2020Q4 mymx Promissory Notes
PromissoryNotes
850000 eur
CY2020Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.025 pure
CY2020Q4 us-gaap Debt Instrument Description
DebtInstrumentDescription
The promissory Notes of €680 and €170, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) March 31, 2021, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes
CY2021Q3 mymx Promissory Notes
PromissoryNotes
1200000 eur
CY2021Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
0.025 pure
CY2021Q3 us-gaap Debt Instrument Description
DebtInstrumentDescription
The promissory Notes of €960 and €240, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) December 31, 2021, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes
CY2022Q2 mymx Promissory Notes
PromissoryNotes
960000 eur
CY2022Q2 us-gaap Investment Interest Rate
InvestmentInterestRate
0.025 pure
CY2022Q3 mymx Promissory Notes
PromissoryNotes
600000 eur
CY2022Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
0.025 pure
CY2022Q3 us-gaap Debt Instrument Description
DebtInstrumentDescription
The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) December 31, 2022, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes
CY2022Q4 mymx Promissory Notes
PromissoryNotes
250000 eur
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.025 pure
CY2022Q4 us-gaap Debt Instrument Description
DebtInstrumentDescription
The promissory Notes of €200 and €50, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) March 31, 2023, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes
CY2023Q1 mymx Promissory Notes
PromissoryNotes
500000 eur
CY2023Q1 us-gaap Investment Interest Rate
InvestmentInterestRate
0.025 pure
CY2023Q1 us-gaap Debt Instrument Description
DebtInstrumentDescription
The promissory Notes of €400 and €100, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) June 30, 2023, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes
CY2023Q2 mymx Promissory Notes
PromissoryNotes
600000 eur
CY2023Q2 us-gaap Investment Interest Rate
InvestmentInterestRate
0.025 pure
CY2023Q2 us-gaap Debt Instrument Description
DebtInstrumentDescription
The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) September 30, 2023, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes
CY2020Q2 mymx Received From Federal Credit Line
ReceivedFromFederalCreditLine
168000 eur
CY2023Q3 us-gaap Investment Interest Rate
InvestmentInterestRate
0.015 pure
us-gaap Interest Paid
InterestPaid
1000 eur
us-gaap Servicing Asset At Amortized Value Risk Characteristics Description
ServicingAssetAtAmortizedValueRiskCharacteristicsDescription
A first amortization installment of Chf 14 (€14) was paid on October 3, 2022. A second amortization installment of Chf 14 (€14) was paid on April 3, 2023. The next amortization of €14 was incurred on September 30, 2023, but is paid on October 2, 2023. The entire loan should be fully amortized and repaid by September 30, 2027
CY2023Q4 mymx Promissory Notes
PromissoryNotes
600000 eur

Files In Submission

Name View Source Status
0001654954-23-014575-index-headers.html Edgar Link pending
0001654954-23-014575-index.html Edgar Link pending
0001654954-23-014575.txt Edgar Link pending
0001654954-23-014575-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mymx-20230930.xsd Edgar Link pending
mymx_10q.htm Edgar Link pending
mymx_ex311.htm Edgar Link pending
mymx_ex312.htm Edgar Link pending
mymx_ex32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mymx-20230930_cal.xml Edgar Link unprocessable
mymx-20230930_def.xml Edgar Link unprocessable
mymx-20230930_lab.xml Edgar Link unprocessable
mymx-20230930_pre.xml Edgar Link unprocessable
mymx_10q_htm.xml Edgar Link completed